Targeting tachykinin receptors in neuroblastoma

Neuroblastoma is the most common extracranial tumor in children. Despite aggressive multimodal treatment, high-risk neuroblastoma remains a clinical challenge with survival rates below 50%. Adding targeted drugs to first-line therapy regimens is a promising approach to improve survival in these pati...

詳細記述

保存先:
書誌詳細
出版年:Oncotarget
主要な著者: Henssen, Anton G., Odersky, Andrea, Szymansky, Annabell, Seiler, Marleen, Althoff, Kristina, Beckers, Anneleen, Speleman, Frank, Schäfers, Simon, De Preter, Katleen, Astrahanseff, Kathy, Struck, Joachim, Schramm, Alexander, Eggert, Angelika, Bergmann, Andreas, Schulte, Johannes H.
フォーマット: Artigo
言語:Inglês
出版事項: Impact Journals LLC 2016
主題:
Research Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5352132/
https://ncbi.nlm.nih.gov/pubmed/27888795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13440
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料